Abstract
OBJECTIVE: To examine the short-term effects of a lipase inhibitor (Orlistat) on physiological and behavioural measures of appetite in response to a high-fat meal.
DESIGN: Randomised, single blind, placebo-controlled, crossover trial.
SUBJECTS: A total of 19 healthy nonobese male subjects.
PROCEDURES: After an overnight fast, subjects ingested a test meal of 2940 kJ (60% fat, 30% CHO, 10% protein) with Orlistat (120 mg) or a placebo, separated by 2 weeks. Appetite, as assessed by a standard line scale, and plasma cholecystokinin (CCK) concentrations were measured prior to and every hour after the test meal for 4 h. Thereafter, subjects ingested a quantified, but self-selected portion of a standardised lunch (15% protein, 37% fat and 45% CHO), before completing a final line scale questionnaire.
RESULTS: The CCK response to the test meal was negatively correlated with BMI in both the Orlistat and placebo trials (R=−0.69 and −0.65, P<0.01). Orlistat administration did not significantly alter the CCK response to the test meal (6.30±3.27 vs 7.36±3.94 pM min, for Orlistat and placebo, P=0.193). Similarly, the line scale measures of appetite and subsequent intake (520±205 vs 554±197 g, P=0.48) were not different between the trials.
CONCLUSION: Orlistat administration did not alter short-term physiological or behavioural measures of satiety in response to a high-fat meal in healthy, nonobese subjects. The CCK response to a test meal may be partly determined by BMI.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Rolls BJ . Carbohydrates, fats and satiety. Am J Clin Nutr 1995; 61 (Suppl): 960S–967S.
Degen L, Matzinger D, Drewe J, Beglinger C . The effect of cholecystokinin in controlling appetite and food intake in humans. Peptides 2001; 22: 1265–1269.
Ballinger A, McLoughlin L, Medbak S, Clark M . Cholecystokinin is a satiety hormone in humans at physiological post-prandial plasma concentrations. Clin Sci (Lond) 1995; 89: 375–381.
Gutzwiller JP, Drewe J, Ketterer S, Hildebrand P, Krautheim A, Beglinger C . Interaction between CCK and a preload on reduction of food intake is mediated by CCK-A receptors in humans. Am J Physiol Regul Integr Comp Physiol 2000; 279: R189–R195.
Beglinger C, Degen L, Matzinger D, D'Amato M, Drewe J . Loxiglumide, a CCK-A receptor antagonist, stimulates calorie intake and hunger feelings in humans. Am J Physiol Regul Integr Comp Physiol 2001; 280: R1149–R1154.
Matzinger D, Gutzwiller JP, Drewe J, Orban A, Engel R, D'Amato M, Rovati L, Beglinger C . Inhibition of food intake in response to intestinal lipid is mediated by cholecystokinin in humans. Am J Physiol 1999; 277 (6 Part 2): R1718–R1724.
Matzinger D, Degen L, Drewe J, Meuli J, Duebendorfer R, Ruckstuhl N, D'Amato M, Rovati L, Beglinger C . The role of long chain fatty acids in regulating food intake and cholecystokinin release in humans. Gut 2000; 46: 688–693.
Liddle RA, Goldfine ID, Rosen MS, Taplitz RA, Williams JA . Cholecystokinin bioactivity in human plasma. Molecular forms, responses to feeding, and relationship to gallbladder contraction. J Clin Invest 1985; 75: 1144–1152.
Hildebrand P, Petrig C, Burckhardt B, Ketterer S, Lengsfeld H, Fleury A, Hadvary P, Beglinger C . Hydrolysis of dietary fat by pancreatic lipase stimulates cholecystokinin release. Gastroenterology 1998; 114: 123–129.
Feinle C, Rades T, Otto B, Fried M . Fat digestion modulates gastrointestinal sensations induced by gastric distention and duodenal lipid in humans. Gastroenterology 2001; 120: 1100–1107.
Borovicka J, Schwizer W, Guttmann G, Hartmann D, Kosinski M, Wastiel C, Bischof-Delaloye A, Fried M . Role of lipase in the regulation of postprandial gastric acid secretion and emptying of fat in humans: a study with orlistat, a highly specific lipase inhibitor. Gut 2000; 46: 774–781.
Schwizer W, Asal K, Kreiss C, Mettraux C, Borovicka J, Remy B, Guzelhan C, Hartmann D, Fried M . Role of lipase in the regulation of upper gastrointestinal function in humans. Am J Physiol 1997; 273 (3 Part 1): G612–G620.
Rolls BJ, Kim-Harris S, Fischman MW, Foltin RW, Moran TH, Stoner SA . Satiety after preloads with different amounts of fat and carbohydrate: implications for obesity. Am J Clin Nutr 1994; 60: 476–487.
French SJ, Murray B, Rumsey RD, Sepple CP, Read NW . Preliminary studies on the gastrointestinal responses to fatty meals in obese people. Int J Obes Relat Metab Disord 1993; 17: 295–300.
Guerciolini R, Radu-Radulescu L, Boldrin M, Dallas J, Moore R . Comparative evaluation of fecal fat excretion induced by orlistat and chitosan. Obes Res 2001; 9: 364–367.
Zhi J, Melia AT, Guerciolini R, Chung J, Kinberg J, Hauptman JB, Patel IH . Retrospective population-based analysis of the dose–response (fecal fat excretion) relationship of orlistat in normal and obese volunteers. Clin Pharmacol Ther 1994; 56: 82–85.
Hill AJ, Blundell JE . Nutrients and behaviour: research strategies for the investigation of taste characteristics, food preferences, hunger sensations and eating patterns in man. J Psychiatr Res 1982; 17: 203–212.
Steyn K, Langenhoven ML, Joubert G, Chalton DO, Benade AJ, Rossouw JE . The relationship between dietary factors and serum cholesterol values in the coloured population of the Cape Peninsula. S Afr Med J 1990; 78: 63–67.
Carriere F, Renou C, Ransac S, Lopez V, De Caro J, Ferrato F, De Caro A, Fleury A, Sanwald-Ducray P, Lengsféld H, Beglinger C, Hadvary P, Verger R, Laugier R . Inhibition of gastrointestinal lipolysis by Orlistat during digestion of test meals in healthy volunteers. Am J Physiol Gastrointest Liver Physiol 2001; 281: G16–G28.
Stubbs RJ, Hughes DA, Johnstone AM, Rowley E, Reid C, Elia M, Stratton R, Delargy H, King N, Blundell JE . The use of visual analogue scales to assess motivation to eat in human subjects: a review of their reliability and validity with an evaluation of new hand-held computerized systems for temporal tracking of appetite ratings. Br J Nutr 2000; 84: 405–415.
Cecil JE . Oral, gastric and intestinal influences on the control of appetite and feeding in humans. Appetite 2001; 36: 235–236.
Flint A, Raben A, Blundell JE, Astrup A . Reproducibility, power and validity of visual analogue scales in assessment of appetite sensations in single test meal studies. Int J Obes Relat Metab Disord 2000; 24: 38–48.
Silberbauer CJ, Jacober B, Langhans W . Dietary fat level and short-term effects of a high-fat meal on food intake and metabolism. Ann Nutr Metab 1998; 42: 75–89.
Acknowledgements
We are grateful to Roche South Africa for partial sponsorship of this research and to Pick and Pay, Clover and Nestle for their generous donations of food. We are also grateful to Judy Belonje and Maglona Paul for their expert technical assistance in performing the glucose and insulin assays, respectively. This study was also partly funded by the Medical Research Council of South Africa, the Nellie Atkinson and Harry Crossley Research Funds of the University of Cape Town.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Goedecke, J., Barsdorf, M., Beglinger, C. et al. Effects of a lipase inhibitor (Orlistat) on cholecystokinin and appetite in response to a high-fat meal. Int J Obes 27, 1479–1485 (2003). https://doi.org/10.1038/sj.ijo.0802436
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.ijo.0802436
Keywords
This article is cited by
-
Gut fat signaling and appetite control with special emphasis on the effect of thylakoids from spinach on eating behavior
International Journal of Obesity (2015)
-
The Use of Green Leaf Membranes to Promote Appetite Control, Suppress Hedonic Hunger and Loose Body Weight
Plant Foods for Human Nutrition (2015)
-
Benefit-Risk Assessment of Orlistat in the Treatment of Obesity
Drug Safety (2014)
-
Fasting and Meal-Induced CCK and PP Secretion Following Intragastric Balloon Treatment for Obesity
Obesity Surgery (2013)